AVANTOR INC (AVTR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AVTR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AVTR | Chief Executive Officer, Tessera Therapeutics | 60 | ["Chief Executive Officer of Tessera Therapeutics, Inc.", "Vice Chairman and President at AbbVie Inc.", "Executive Vice President, Research & Development at AbbVie Inc.", "Chief Scientific Officer at AbbVie Inc.", "Senior Vice President, Global Development at Amgen, Inc.", "Chief Medical Officer at Amgen, Inc.", "M.D. from Johns Hopkins University", "Residency and Fellowship Training at Massachusetts General Hospital and Harvard Medical School", "Bachelor\u2019s Degree in Biochemistry from the University of Maryland"] | ["Compensation & Human Resources (Chair)", "Science & Technology", "Compensation & Human Resources"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VTRS | Chief Executive Officer; Chair of the Science and Technology Committee | 60 | ["CEO and Public Company Management", "Finance", "Accounting", "Capital Markets", "Global Business", "Strategy and M&A Experience", "Human Capital Management", "Healthcare Industry Experience"] | ["Audit", "Science and Technology", "Chair", "Audit Committee", "Science and Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
AGE: 60 DIRECTOR SINCE 2020 Chief Executive Officer of Tessera Therapeutics, Inc. EXPERIENCE Tessera Therapeutics, Inc., a biotechnology company (2022-Present) Chief Executive Officer AbbVie Inc., a pharmaceutical company (2014-2022) Vice Chairman and President Executive Vice President, Research & Development Chief Scientific Officer Amgen, Inc., a global biotechnology company (2004-2014) Senior Vice President, Global Development Chief Medical Officer EDUCATION M.D. from Johns Hopkins University Residency and Fellowship Training at Massachusetts General Hospital and Harvard Medical School Bachelor s Degree in Biochemistry from the University of Maryland VALUE TO OUR BOARD The Board benefits from Dr. Severino s extensive leadership experience, including as a chief executive officer, and his current and past experience in research and development and corporate strategy for leading companies focused on developing life-saving therapies for patients. OTHER PUBLIC COMPANY BOARDS Viatris, Inc. (2025-Present) COMMITTEES Compensation & Human Resources (Chair) Science & Technology SKILLS INDEPENDENT